Insulin

FDA-approved context Hormonal Health 2 sources

Insulin is a vital peptide hormone produced by the pancreas that regulates carbohydrate, fat, and protein metabolism. It facilitates the cellular uptake of glucose from the blood, making it essential for energy storage and the clinical management of diabetes.

01Dosing reference

Amount

Highly individualized (e.g., 0.1-1.0 units/kg/day)

Frequency

Varies from once daily to multiple times a day with meals

Cycle

Continuous daily use for insulin-dependent individuals

Reference figures, not a recommendationThese values reflect amounts described in the literature and vendor documentation this database indexes. Use the reconstitution calculator to convert them into syringe units.

02Mechanism of action

Insulin receptor binding

Insulin binds to the insulin receptor (IR), a receptor tyrosine kinase located on the cell membrane of target tissues.

Intracellular signaling cascade

Receptor activation triggers pathways such as PI3K/AKT, leading to the translocation of GLUT4 transporters to the cell surface.

Cellular glucose uptake

GLUT4 allows glucose to enter the cell, lowering blood glucose levels and promoting energy storage.

03Human evidence

Effective management of Type 1 and Type 2 Diabetes

Extensive clinical trials and decades of clinical use demonstrate insulin's efficacy in lowering HbA1c and preventing diabetic complications.

Risk of hypoglycemia and weight gain

Clinical data consistently shows that intensive insulin therapy increases the risk of severe hypoglycemia and promotes weight gain.

04Preclinical evidence

Regulation of lipogenesis and glycogen synthesis

Animal models and cell cultures show insulin strongly stimulates glycogen synthesis in the liver and lipid synthesis in adipose tissue.

Neuroprotective effects in the brain

Rodent models suggest intranasal insulin may improve memory and have neuroprotective effects in Alzheimer's disease models.

05What is known vs. unknown

Reasonably established

Essential for life and the primary regulator of blood glucose levels.
Used clinically for the treatment of Type 1 diabetes, advanced Type 2 diabetes, and gestational diabetes.
Available in various formulations with different onset times and durations of action (e.g., rapid-acting, long-acting).
Acts as an anabolic hormone that promotes the storage of glucose, amino acids, and fatty acids.

Unknowns & limits

The exact mechanisms linking chronic hyperinsulinemia to cardiovascular disease and cancer risk remain an active area of research.
Optimal delivery methods (e.g., oral, smart insulins) to mimic physiological pancreatic secretion without hypoglycemia risk are still under development.

06Safety & regulatory context

Regulatory statusInsulin is an FDA-approved medication for the treatment of diabetes mellitus. The most significant safety concern is hypoglycemia (low blood sugar), which can be life-threatening if untreated. Other side effects include weight gain, lipodystrophy at injection sites, and potential allergic reactions. It requires careful dosing, blood glucose monitoring, and patient education. Overdose can lead to severe hypoglycemia, coma, and death.

07Compared with Glucagon

Insulin vs. Glucagon

Key difference

Insulin lowers blood glucose by promoting cellular uptake, whereas glucagon raises blood glucose by stimulating hepatic glycogenolysis and gluconeogenesis.

When researchers discuss each

Insulin is discussed in the context of lowering high blood sugar and anabolic processes, while glucagon is discussed for treating severe hypoglycemia and catabolic states.

08Glossary

Hypoglycemia

A condition characterized by an abnormally low level of blood sugar (glucose).

GLUT4

An insulin-regulated glucose transporter found primarily in adipose tissues and striated muscle.

Hyperinsulinemia

A condition in which there are excess levels of insulin circulating in the blood relative to the level of glucose.

09Knowledge check

Q1What is the primary mechanism by which insulin lowers blood glucose levels?

Q2Which of the following is the most common and potentially dangerous side effect of insulin therapy?

Q3Which statement best reflects a documented limitation or active research gap noted in the dossier about insulin?

Q4According to the dossier's stated comparison, how are insulin and glucagon typically contrasted in research discussions?

Q5Which description of insulin's regulatory and safety context is supported by the dossier?

10Sources

More in Hormonal Health

See all

Kisspeptin-10

Hormonal Health

Human clinical

Kisspeptin-10 is a potent neuropeptide that acts as an upstream regulator of the hypothalamic-pituitary-gonadal (HPG) axis. Research shows it stimulates the release of gonadotropin-releasing hormone (GnRH), subsequently increasing luteinizing hormone (LH), follicle-stimulating hormone (FSH), and testosterone levels. It is heavily studied for its potential in treating infertility, hypogonadism, and reproductive disorders.

100-300 mcg per dose

Gonadorelin

Hormonal Health

FDA-approved context

Gonadorelin is a synthetic version of gonadotropin-releasing hormone (GnRH). It stimulates the anterior pituitary gland to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which in turn stimulate the gonads to produce testosterone and sperm in males, and estrogen and eggs in females.

100-200 mcg per dose

hCG (Human Chorionic Gonadotropin)

Hormonal Health

FDA-approved context

hCG is a hormone naturally produced during pregnancy that mimics luteinizing hormone (LH) in the body. In research and clinical settings, it is widely used to stimulate testosterone production, preserve fertility, and treat hypogonadism in men, as well as to induce ovulation in women.

250-500 IU

Research and educational use onlyNothing on this site is medical advice, a prescription, or a recommendation for human use. Compounds documented here are research chemicals. Consult a qualified clinician before making any health decision.